Reviva Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 15
- Market Cap
- -
- Website
- http://www.revivapharma.com
- Introduction
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Reviva Pharmaceuticals
- Target Recruit Count
- 690
- Registration Number
- NCT05184335
- Locations
- 🇺🇸
Reviva site, Richardson, Texas, United States
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Phase 2
Completed
- Conditions
- Acute SchizophreniaSchizoaffective Disorder
- Interventions
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2015-01-26
- Lead Sponsor
- Reviva Pharmaceuticals
- Target Recruit Count
- 234
- Registration Number
- NCT01490086
- Locations
- 🇲🇾
Reviva Site, Ridzuan, Malaysia
🇵🇭Reviva site, Subangdaku, Philippines
© Copyright 2025. All Rights Reserved by MedPath